| __timestamp | ADMA Biologics, Inc. | Axsome Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 9517014 | 4279200 |
| Thursday, January 1, 2015 | 7015946 | 6776987 |
| Friday, January 1, 2016 | 7688238 | 21199860 |
| Sunday, January 1, 2017 | 6229587 | 19957616 |
| Monday, January 1, 2018 | 3926120 | 23495055 |
| Tuesday, January 1, 2019 | 2343848 | 53647067 |
| Wednesday, January 1, 2020 | 5907013 | 70244579 |
| Friday, January 1, 2021 | 3646060 | 58060725 |
| Saturday, January 1, 2022 | 3613764 | 57947447 |
| Sunday, January 1, 2023 | 3300000 | 97944000 |
Unlocking the unknown
In the competitive world of biotechnology, innovation is the lifeblood of success. Over the past decade, Axsome Therapeutics, Inc. and ADMA Biologics, Inc. have demonstrated contrasting approaches to research and development (R&D) investment. From 2014 to 2023, Axsome Therapeutics has consistently outpaced ADMA Biologics, with R&D expenses peaking at nearly 98 million in 2023, a staggering 900% increase from 2014. In contrast, ADMA Biologics' investment has seen a decline, with a 65% drop from its 2014 peak of approximately 9.5 million. This divergence highlights Axsome's aggressive pursuit of innovation, potentially positioning it as a leader in the biotech sector. As investors and stakeholders evaluate these trends, the question remains: will Axsome's substantial R&D spending translate into groundbreaking therapies and market success?
Comparing Innovation Spending: Merck & Co., Inc. and ADMA Biologics, Inc.
R&D Spending Showdown: Genmab A/S vs Axsome Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Viatris Inc. and ADMA Biologics, Inc.
R&D Insights: How Bio-Techne Corporation and ADMA Biologics, Inc. Allocate Funds
Research and Development Expenses Breakdown: Ionis Pharmaceuticals, Inc. vs ADMA Biologics, Inc.
Research and Development: Comparing Key Metrics for Axsome Therapeutics, Inc. and TG Therapeutics, Inc.
R&D Spending Showdown: Axsome Therapeutics, Inc. vs Amneal Pharmaceuticals, Inc.
Selling, General, and Administrative Costs: Axsome Therapeutics, Inc. vs ADMA Biologics, Inc.
R&D Spending Showdown: Axsome Therapeutics, Inc. vs Taro Pharmaceutical Industries Ltd.
Research and Development: Comparing Key Metrics for TG Therapeutics, Inc. and ADMA Biologics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for ADMA Biologics, Inc. and Iovance Biotherapeutics, Inc.
Research and Development: Comparing Key Metrics for ADMA Biologics, Inc. and Viridian Therapeutics, Inc.